» Articles » PMID: 21292816

Inappropriate Drug Use and Mortality in Community-dwelling Elderly with Impaired Kidney Function--the Three-City Population-based Study

Overview
Date 2011 Feb 5
PMID 21292816
Citations 38
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Glomerular filtration rate (GFR) decline with age increases the risk of inappropriate dosing of drugs. We investigated the determinants and the mortality associated with the use of drugs that are contraindicated or require dose adjustment according to kidney function among the community-dwelling elderly.

Methods: The Three-City population-based study included 8701 participants ≥65 years from 1999 to 2001. Exposure to the risk of inappropriate drug dosage was defined as reported use of either a contraindicated drug or one requiring dose adjustment according to the individual baseline glomerular filtration rate estimated (eGFR) with the Modification of Diet in Renal disease study equation. Six-year mortality was analysed using Cox models adjusted for several sociodemographic, biologic and clinical risk factors.

Results: The overall percentage of exposure to the risk of inappropriate drug use was 13.3% (contraindication, 0.8%): it was 52.5% (4.5%) in those with an eGFR of 30-59 and 96% (48%) in those <30 mL/min/1.73 m(2). Antihypertensive agents, fibrates and psycholeptics accounted for most of the drugs with dosing recommendations and antidiabetic agents and antihistamines for those contraindicated. Individuals at risk were more likely to be men, older, and under treatment for hypertension or hypercholesterolemia. Exposure to either risk was independently related to higher all-cause mortality (hazard ratio 1.4, 95% confidence interval 1.0-1.9) in participants with eGFR <60 mL/min/1.73 m(2).

Conclusions: Contraindicated drug prescription was uncommon but >10% of the population took drugs requiring renal dosing adjustments. Regular monitoring of eGFR may prevent excess mortality associated with inappropriate drug prescription in the elderly.

Citing Articles

Renally Inappropriate Medications in the Old Population: Prevalence, Risk Factors, Adverse Outcomes, and Potential Interventions.

AlQashqri H Cureus. 2023; 15(11):e49111.

PMID: 38125263 PMC: 10732268. DOI: 10.7759/cureus.49111.


Hypoglycemia risk with inappropriate dosing of glucose-lowering drugs in patients with chronic kidney disease: a retrospective cohort study.

Li Y, Chang Y, Chou Y, Hsu C Sci Rep. 2023; 13(1):6373.

PMID: 37076583 PMC: 10115797. DOI: 10.1038/s41598-023-33542-z.


Appropriateness of drug prescriptions in patients with chronic kidney disease in primary care: a double-center retrospective study.

Ruiz-Boy S, Rodriguez-Reyes M, Clos-Soldevila J, Rovira-Illamola M BMC Prim Care. 2022; 23(1):323.

PMID: 36513993 PMC: 9747536. DOI: 10.1186/s12875-022-01931-4.


Deprescribing Opportunities for Hospitalized Patients With End-Stage Kidney Disease on Hemodialysis: A Secondary Analysis of the MedSafer Cluster Randomized Controlled Trial.

Moryousef J, Bortolussi-Courval E, Podymow T, Lee T, Trinh E, McDonald E Can J Kidney Health Dis. 2022; 9:20543581221098778.

PMID: 35586025 PMC: 9109480. DOI: 10.1177/20543581221098778.


Using Machine Learning to Identify Patients at High Risk of Inappropriate Drug Dosing in Periods with Renal Dysfunction.

Kaas-Hansen B, Rodriguez C, Placido D, Thorsen-Meyer H, Nielsen A, Derian N Clin Epidemiol. 2022; 14:213-223.

PMID: 35228820 PMC: 8881932. DOI: 10.2147/CLEP.S344435.


References
1.
Moranne O, Froissart M, Rossert J, Gauci C, Boffa J, Haymann J . Timing of onset of CKD-related metabolic complications. J Am Soc Nephrol. 2008; 20(1):164-71. PMC: 2615728. DOI: 10.1681/ASN.2008020159. View

2.
Gill J, Malyuk R, Djurdjev O, Levin A . Use of GFR equations to adjust drug doses in an elderly multi-ethnic group--a cautionary tale. Nephrol Dial Transplant. 2007; 22(10):2894-9. DOI: 10.1093/ndt/gfm289. View

3.
Frimat L, Siewe G, Loos-Ayav C, Briancon S, Kessler M, Aubrege A . [Chronic kidney disease: do generalists and nephrologists differ in their care?]. Nephrol Ther. 2006; 2(3):127-35. DOI: 10.1016/j.nephro.2006.04.007. View

4.
Noize P, Bazin F, Dufouil C, Lechevallier-Michel N, Ancelin M, Dartigues J . Comparison of health insurance claims and patient interviews in assessing drug use: data from the Three-City (3C) Study. Pharmacoepidemiol Drug Saf. 2009; 18(4):310-9. DOI: 10.1002/pds.1717. View

5.
Fink J, Brown J, Hsu V, Seliger S, Walker L, Zhan M . CKD as an underrecognized threat to patient safety. Am J Kidney Dis. 2009; 53(4):681-8. PMC: 3710448. DOI: 10.1053/j.ajkd.2008.12.016. View